NASAGENT

This brand name is authorized in Nigeria.

Active ingredients

The drug NASAGENT contains one active pharmaceutical ingredient (API):

1	Gentamicin UNII 8X7386QRLV - GENTAMICIN SULFATE
	Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits.
	Read more about Gentamicin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7134	Injection	NASAGENT INJECTION INJ 80 mg/mL 2MLX5AMPOULESX2	NASAGENT INJECTION GENTAMYCIN SULPHATE 80MG/2ML GENTAMYCIN 80MG/2ML B4-7134 Drugs Imported Products 2MLX5AMPOULESX2 Prescription Only Medicine (POM) 11/08/2022 NASAJONES INDUSTRIES LTD, NO. 31 OFFICE COMPLEX, MIDDLE ROAD BY ADO BAYERO SQUARE, SABON GARI 0 nasajones2021@gmail.com GUIZHOU TIANDI PHARACEUTICAL CO., LTD, NO 6 BAOKAND ROAD, XINGYI CITY, GUIZHOU PROVINCE, CHINA, China	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01GB03	Gentamicin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7134